Clendeninn Neil James 4
4 · ONCOGENEX PHARMACEUTICALS, INC. · Filed Jun 4, 2012
Insider Transaction Report
Form 4
Clendeninn Neil James
Director
Transactions
- Award
Restricted Stock Units
2012-05-31+2,000→ 2,000 total→ Common (2,000 underlying) - Award
Stock Option (right to buy)
2012-05-31+4,000→ 4,000 totalExercise: $12.56Exp: 2022-05-31→ Common (4,000 underlying)
Footnotes (4)
- [F1]The options vest 100% on the earlier of May 31, 2013 or the date immediately prior to the issuer's next annual meeting of stockholders.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
- [F3]The restricted stock units vest 100% on the earlier of the first anniversary of the grant date or the date immediately prior to the issuer's next annual meeting of stockholders.
- [F4]The restricted stock units expire 30 days from the earlier of the first anniversary of the grant date or the date of the Issuer's next annual meeting of stockholders.